User Experience from Aulia Hospital, Indonesia: FIRAPY Supports Dialysis Workflow and Blood Flow Management

May 12, 2026

FIRAPY continues to be used in daily hemodialysis care across Asia. In this user experience video from RSU Aulia Jakarta, Indonesia, a dialysis nurse and hemodialysis patients share their real-world observations after using FIRAPY as part of vascular access care. Their comments highlight how FIRAPY may support nursing workflow, help manage low blood flow rate during dialysis, and provide a warm and comfortable treatment experience for patients.

Video Summary

In this video, a dialysis nurse and hemodialysis patients from RSU Aulia Jakarta share their experience with FIRAPY in daily dialysis care. The nurse explains that FIRAPY helps support the work of dialysis nurses by reducing the risk of dialysis alarms and assisting patients whose blood flow rate, or QB, is low during treatment.

One patient shares that after using FIRAPY, his QB increased from 150 to 250 mL/min. Another patient explains that he had previously maintained a QB of around 300 mL/min, but after developing a problem with his Cimino fistula, his QB decreased to 200 mL/min, and sometimes 180 mL/min. Since using FIRAPY, he reports that his QB has improved to 250 mL/min. He also describes the treatment experience as warm and comfortable.

This video reflects real-world user experience shared by healthcare professionals and patients at RSU Aulia Jakarta. Individual results may vary depending on patient condition, vascular access status, and clinical management. The observations shared in this video should be interpreted as user experience rather than a controlled clinical study.

Want to know more?



Contact us for more detail


Learn more
Questions to FIRAPY
August 19, 2026
A new study published in Cells has provided further insight into the molecular responses of arterial endothelial cells following far-infrared (FIR) irradiation.  The study, conducted by researchers from Gunma Paz University, Japan, investigated the effects of FIR on human femoral artery endothelial cells (HFAECs) using an integrated multi-omics approach combining transcriptomics, proteomics, and phosphoproteomics. FIR irradiation was delivered using the WSTM TY101F far-infrared therapy unit manufactured by WS Far Infrared Medical Technology.
FIRAPY at MEDICA 2026 | Innovative Care for Dialysis Patients
August 19, 2026
Meet FIRAPY at MEDICA 2026 in Düsseldorf, November 16–19. Visit Hall 16, Booth B03-2 to explore innovative far infrared therapy for dialysis patient care.
More Posts